(S (NP-SBJ (NN Calcineurin) (NNS mutants)) (VP (VBP render) (S (NP-SBJ (NN T) (NNS lymphocytes)) (ADJP-PRD (JJ resistant) (PP (TO to) (NP (NN cyclosporin) (NN A)))))) (. .))
(S (NP-SBJ-29 (DT The) (NNS immunosuppressants) (NP-COOD (NP (NP (NN cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN CsA)) (-RRB- -RRB-))) (CC and) (NP (NN FK506)))) (VP (VBP have) (VP (VBN been) (ADVP (RB widely)) (VP (VBN used) (NP-30 (-NONE- *-29)) (S (NP-SBJ (-NONE- *-30)) (VP (TO to) (VP (VP-COOD (VP (VB prevent) (NP (-NONE- *RNR*-31))) (CC and) (VP (VB treat) (NP (-NONE- *RNR*-31)))) (NP-31 (NP (NN graft) (NN rejection)) (PP-TMP (IN after) (NP (JJ human) (NP-COOD (NP (NN organ)) (CC and) (NP (NN tissue))) (NNS transplantations)))))))))) (. .))
(S (NP-SBJ-COOD-32 (NP (NN CsA)) (CC and) (NP (NN FK506))) (VP (VBP associate) (PP (IN with) (NP (NP (JJ intracellular) (VBG binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (ADVP (FW i.e.)) (, ,) (NP-COOD (NP (NP (NN CsA)) (PP (IN with) (NP (NN cyclophilin) (NN A)))) (CC and) (NP (NP (NN FK506)) (PP (IN with) (NP (NN FKBP12)))))) (-RRB- -RRB-)))) (S (NP-SBJ (-NONE- *-32)) (VP (TO to) (VP (VB form) (NP (NP (NN (drug protein)) (NNS complexes)) (SBAR (WHNP-33 (WDT that)) (S (NP-SBJ-34 (-NONE- *T*-33)) (VP (VBP suppress) (NP (DT the) (JJ immune) (NN system)) (PP (IN by) (S (NP-SBJ (-NONE- *-34)) (VP (VBG preventing) (NP (NP (NN activation)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN in) (NN response) (TO to) (NP (NN antigen) (NN presentation))))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ common) (NN target)) (PP (IN of) (NP-COOD (NP (NN CsA)) (CC and) (NP (NN FK506))))) (VP (VBZ is) (NP-PRD (NP (NN calcineurin)) (, ,) (NP (NP (DT a) (ADJP-COOD (ADJP (JJ (calmodulin-regulated Ca2+))) (, ,) (ADJP (JJ (threonine-specific serine)))) (NN protein) (NN phosphatase)) (SBAR (WHNP-35 (WDT that)) (S (NP-SBJ (-NONE- *T*-35)) (VP (VBZ regulates) (NP (NP (DT the) (JJ nuclear) (NN import)) (PP (IN of) (NP (NP (NP (DT a) (NN transcription) (NN factor)) (, ,) (NP (NN NF-AT)) (, ,)) (VP (VBN required) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (NN T) (NN cell) (NN activation) (NNS genes))))))))))))))) (. .))
(S (PP (IN In) (NP (JJ previous) (NNS studies))) (, ,) (NP-SBJ (PRP we)) (VP (VBD identified) (NP (NP (NN calcineurin) (NNS mutations)) (SBAR (WHNP-36 (WDT that)) (S (NP-SBJ (-NONE- *T*-36)) (VP-COOD (VP (VBP block) (NP (NP (NN binding)) (PP (IN by) (NP (DT the) (ADJP-COOD (ADJP (NN cyclophilin) (NN (CsA A))) (CC or) (ADJP (NN (FK506 FKBP12)))) (NNS complexes))))) (CC and) (RB thereby) (VP (VBP render) (S (NP-SBJ (NN yeast) (NNS cells)) (ADJP-PRD (JJ resistant) (PP (TO to) (NP (NP (DT the) (JJ antifungal) (NNS effects)) (PP (IN of) (NP-COOD (NP (NN CsA)) (CC or) (NP (NN FK506)))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ corresponding) (NNS mutations)) (PP (IN in) (NP (JJ murine) (NN calcineurin)))) (VP (VBP render) (S (NP-SBJ (DT the) (NN T) (NN cell) (NN receptor) (NN signal) (NN transduction) (NN cascade) (NN CsA)) (ADJP-PRD (JJ resistant) (PP (IN in) (NP (JJ human) (NN Jurkat) (NN T) (NNS cells))))))))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS findings)) (VP-COOD (VP (VBP support) (NP (DT the) (ADJP (RB recently) (VBN determined)) (NN calcineurin) (NN X-ray) (NN crystal) (NN structure))) (, ,) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP-SBJ (NN calcineurin)) (VP (VBZ is) (NP-PRD (NP (DT the) (RB only) (JJ CsA-sensitive) (NN component)) (VP (VBG limiting) (NP (NP (NN signaling)) (PP (IN from) (NP (DT the) (NN T) (NN cell) (NN receptor))) (PP (TO to) (NP (DT the) (NN nucleus))))))))))) (, ,) (CC and) (VP (VBP suggest) (NP (NP (DT a) (NN means)) (SBAR (WHADVP-37 (-NONE- 0)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB render) (S (NP-SBJ-COOD (NP (NNS cells)) (CC and) (NP (NNS tissues))) (ADJP-PRD (JJ resistant) (PP (TO to) (NP (NP (DT the) (JJ toxic) (JJ side) (NNS effects)) (PP (IN of) (NP-COOD (NP (NN CsA)) (CC and) (NP (NN FK506)))))))) (ADVP (-NONE- *T*-37))))))))) (. .))
